These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 3129281)

  • 1. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN; Hinkle PM
    Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1982 Feb; 110(2):352-8. PubMed ID: 6799271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone rapidly stimulates a biphasic secretion of prolactin and growth hormone in GH4C1 rat pituitary tumor cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Jan; 116(1):73-82. PubMed ID: 3917255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of intracellular proteins related to the multihormonal regulation of prolactin: comparison of normal anterior pituitary cells in culture with the tumor-derived GH cell lines.
    Beretta L; Boutterin MC; Sobel A
    Endocrinology; 1988 Jan; 122(1):40-51. PubMed ID: 3121285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
    Lamberts SW; Verleun T; Hofland L; Oosterom R
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1342-7. PubMed ID: 3782422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and prolactin secretion in cultured somatomammotroph cells.
    Kashio Y; Chomczynski P; Downs TR; Frohman LA
    Endocrinology; 1990 Sep; 127(3):1129-35. PubMed ID: 1974845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
    Jaquet P; Gunz G; Grisoli F
    Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MtTW-10 pituitary tumor cells: galanin gene expression and peptide secretion.
    Hyde JF; Morrison DG; Moore JP; Howard G
    Endocrinology; 1993 Dec; 133(6):2588-93. PubMed ID: 7694842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.